Nav: Home

Surrey develops hepatitis C model that could help improve treatment

May 29, 2018

The University of Surrey has created a new mathematical model that details how the Hepatitis C (HCV) infection develops and behaves more accurately than previous models. This new model has the potential to improve treatment for the infection that affects 215,000 people in the United Kingdom.

HCV is a virus that infects the liver and, if left untreated, can potentially be life-threatening. The virus is usually spread through blood to blood contact and often doesn't have any noticeable symptoms until the liver is significantly damaged. When symptoms surface - such as tiredness, loss of appetite and vomiting - they are regularly mistaken for other conditions.

In a new paper published by the journal Viruses, Professor of Mathematics Philip Aston proposes a new mathematical model that may give clinicians and drug manufacturers a better understanding of the effect of drug treatment on the virus. The model was developed by taking account of recent biological insights into the dynamics of the infection and incorporating these into the model.

The new model has given rise to three recommendations for changes in the treatment of HCV:
  • If the infection is caught and treated in the early stages, then a lower drug dose may be effective in eliminating the infection.

  • If the concentration of the virus in a patient's blood increases after their treatment ends, then continuing with a low level of drug treatment may keep their infection at a small and manageable level.

  • The drug dose could be reduced as treatment progresses which would reduce the cost of treatment as well as providing a reduction in side effects for the patient.

According to the World Health Organisation, there are an estimated 71 million people in the world that have chronic HCV infection which, if left untreated, may result in cirrhosis of the liver or liver cancer. Around 1.8 million new HCV infections occur each year and almost 400,000 people die each year from the infection.

Philip Aston, Professor of Mathematics at the University of Surrey and author of the paper, said: "We have developed a mathematical model that is better able to predict the dynamics of hepatitis C infection during treatment. We believe that this new model provides an opportunity to improve the treatment for patients who are suffering from this illness."
-end-
Note to editors

The paper: A New Model for the Dynamics of Hepatitis C Infection: Derivations, Analysis and Implications; Viruses 10(4), 195, April 2018.

Professor Philip Aston is available for interview.

University of Surrey

Related Hepatitis Articles:

Hepatitis C increasing among pregnant women
Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country's increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia.
WHO's Global Hepatitis Report sets baseline to eliminate viral hepatitis by 2030
The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO), which includes new data on the prevalence and global burden of viral hepatitis.
Elimination of viral hepatitis by 2030: What's needed and how do we get there?
This first European Action Plan provides an important driver to aid countries in their fight against viral hepatitis, to which ECDC had the opportunity to contribute directly.
Discovery of new Hepatitis C virus mechanism
Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus with the potential of improving pathological liver conditions.
Is Europe ready to eliminate viral hepatitis?
Currently, Europe records around 57,000 newly diagnosed acute and chronic cases of hepatitis B and C each year.
Why baby boomers need a hepatitis C screening
Hepatitis C affects a disproportionate amount of older Americans, born between 1945 and 1965.
Counterattack of the hepatitis B virus
The hepatitis B virus (HBV) infects liver cells. Drugs are available to treat HBV, but they rarely cure the infection, and so the virus typically returns after the treatment ends.
Hepatitis C tied to increased risk of Parkinson's
The hepatitis C virus may be associated with an increased risk of developing Parkinson's disease, according to a study published in the Dec.
The hepatitis A virus is of animal origin
The hepatitis A virus can trigger acute liver inflammation which generally has a mild course in small children but which can become dangerous in adults.
Modeling the helicase to understand hepatitis C
NS3 is an enzyme specific to the hepatitis C virus.

Related Hepatitis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...